Find Clarity About Basal Cell Nevus Syndrome with SUFU Gene Testing
Living with uncertainty about inherited cancer risks can be overwhelming. If you or your family members have experienced multiple basal cell carcinomas, jaw cysts, or other symptoms of basal cell nevus syndrome, you deserve answers. Our SUFU Gene NGS Genetic DNA Test provides the definitive clarity you need to take control of your health journey.
Understanding Your SUFU Gene Test
This advanced genetic test examines the SUFU gene using Next-Generation Sequencing (NGS) technology – the gold standard in genetic analysis. The SUFU gene plays a crucial role in preventing uncontrolled cell growth, and mutations in this gene are strongly associated with basal cell nevus syndrome (also known as Gorlin syndrome).
Our test doesn’t just provide results – it gives you understanding. Through comprehensive genetic counselling, we help map your family’s health history and explain exactly what the SUFU gene means for your personal cancer risk profile.
Who Should Consider This Test?
This test is particularly important if you experience:
- Multiple basal cell carcinomas appearing before age 30
- Jaw cysts or unusual dental issues
- Palmar or plantar pits (small depressions in hands/feet)
- Family history of basal cell nevus syndrome
- Early-onset cancers in family members
- Medulloblastoma (brain tumour) in childhood
Many South African patients in Johannesburg, Cape Town, and Durban have found life-changing answers through genetic testing when facing these symptoms.
Why Early Detection Matters for Your Health
Knowing your genetic status empowers you to:
- Implement proactive cancer screening and prevention strategies
- Make informed family planning decisions
- Reduce anxiety through definitive answers
- Access appropriate medical monitoring and care
- Potentially prevent serious health complications
- Provide valuable information for your children and relatives
Early detection through genetic testing can significantly improve health outcomes and provide peace of mind for you and your loved ones.
Understanding Your Test Results
We know waiting for genetic results can be stressful. That’s why we provide clear, compassionate explanations of your findings:
- Positive Result: A mutation was found in the SUFU gene. Our genetic counsellors will guide you through next steps, including appropriate screening protocols and family testing recommendations.
- Negative Result: No SUFU gene mutation was detected. This significantly reduces your risk of basal cell nevus syndrome, though continued medical follow-up may still be recommended.
- Variant of Uncertain Significance: Rarely, we find genetic changes whose significance isn’t yet known. We’ll explain what this means and provide ongoing updates as research advances.
Regardless of your results, you’ll receive personalised guidance from our expert team.
Transparent Pricing – Exceptional Value
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| SUFU Gene NGS Test | ZAR 9,350 | ZAR 6,700 | ZAR 2,650 |
| Genetic Counselling Session | INCLUDED | ||
| Family Pedigree Analysis | INCLUDED | ||
| Results Explanation | INCLUDED | ||
Price includes all professional services, laboratory analysis, and comprehensive reporting.
Why Trust Oracle Genomics?
- Nationwide Coverage: Serving patients across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Expert Team: Working with qualified oncologists and genetic specialists
- Advanced Technology: Using NGS – the most accurate genetic testing method available
- Rapid Turnaround: Results typically within 3-4 weeks
- Multiple Sample Options: Blood, extracted DNA, or simple FTA card blood spot
- Complete Support: From initial consultation through results interpretation
Take the First Step Toward Clarity Today
Don’t let uncertainty about inherited cancer risks control your life. Our SUFU Gene Test provides the answers you need to make informed health decisions.
Your health journey matters. Take control today with definitive genetic testing from South Africa’s trusted genomics provider.
